According to the Centers for Disease Control (CDC), 61 million Americans — 25 percent of the population — currently suffer from cardiovascular disease (CVD). The term cardiovascular disease covers a broad spectrum of disorders that include high blood pressure, coronary heart disease (heart attack and chest pain), stroke, birth defects of the heart and blood vessels, and congestive heart failure. Every year heart attacks and stroke cause more than 930,000 deaths in the United States, making CVD the leading cause of death and accounting for 40 percent of deaths from all causes. And while CVD primarily kills people 65 and older, incidence of sudden deaths from heart disease is rising in people aged 15 to 34. Reducing serum cholesterol levels — especially the low-density (LDL) fraction — is a well-established, effective strategy for preventing cardiovascular disease and reducing coronary events and mortality. Unfortunately a recent report in the journal Circulation found that between 1988 and 2000 average total serum cholesterol concentrations in the US population declined by a mere 1%. And while 91% of respondents to a survey conducted by the American Heart Association felt it was "important to them personally to have a healthy cholesterol level," fewer than 50% knew their own cholesterol level, and 53% either didn’t know, or overestimated, the recommended cholesterol level for a healthy adult. Compounding the problem, only a fraction of those at risk of cardiovascular disease are utilizing pharmaceutical and nutritional strategies known to reduce cholesterol levels. According to estimates based on data gathered from the National Health and Nutrition Examination Survey III (NHANES III), only 1.4 million (6.6%) of 21.1 million Americans eligible for cholesterol-lowering drug therapy under National Cholesterol Education Program (NCEP) guidelines were actually using such therapy. And when researchers examined responses gathered from 13,990 patients they discovered that fewer than 4% of those diagnosed with hypercholesterolemia (elevated cholesterol) were taking vitamins or supplements known to reduce cholesterol. Concerned with the persistent failure of conventional strategies to significantly improve cholesterol profiles and reduce incidence of cardiovascular diseases, a broad coalition of medical researchers and scientists are now calling for a massive increase in the use of cholesterol-lowering drugs, particularly the family of pharmaceuticals known as statins. Unfortunately statin drugs, while very effective, also have a number of serious side effects that understandably compromise patient compliance. Additionally, statin drugs are expensive to use—depending on the drug and the dosage, statin therapy can cost between $63-$228 per month. Now a newly available, all-natural supplement has been shown in human studies to significantly lower cholesterol levels — particularly LDL cholesterol, triglycerides, and ApoB — to aid in reducing ones risk of developing cardiovascular disease. The supplement, Sytrinol, is an important option for health-conscious consumers seeking a safe, effective and convenient solution for lowering cholesterol levels without the side effects and expense of pharmaceutical drugs.

• SUITABLE FOR VEGANS As s food supplement for adults, one (1) vegetable capsule daily, preferably at a mealtime, or as directed by a healthcare practitioner. Product Facts One (1) vegetable capsule provides: Sytrinol ™ 150mg[Patented proprietary blend of natural citrus] (Citrus Nobilis lour)(peel) and Palm Fruit extract (Elaeis guineensis) (fruit)Encapsulated with these natural ingredients:Vegetable Capsule Shell (hydroxyproplmethyl cellulose)Bulking Agent:microcrystalline celluloseCellulose gumAnti-caking agents:Vegetable Magnesium Stearate*, Silicon Dioxide*Made with vegetable stearic acid 60 Vegetable Capsules